In The News Posted April 22, 2022 Share Posted April 22, 2022 Terran avanzará en el desarrollo de dos terapias de fase 3 para el SNC de Sanofi La transacción incluye derechos exclusivos a nivel mundial para el desarrollo y la comercialización en todos los campos de uso NUEVA YORK, 21 de abril de 2022 /PRNewswire/ -- Terran Biosciences, Inc....View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now